Related Articles:
December 21, 2011
With the year of 2011 under the microscope, it’s amazing to see how technology and discoveries have made some amazing medical news in the last year. Not only have new technologies solved existing medical problems, but we have also discovered how problems can be redefined and with growing amounts of developments in increase in scope for clinical research jobs to conduct tests for all the new theses. The FDA has made some interesting announcements as well as research from the WHO coming to light and proving previously unknown findings. In looking back on the medical news of 2011 we can understand recent and breaking discoveries and how these will change our lives into 2012.
1) The FDA approves Type 2 Diabetes Drug – Linagliptin is a new to the market tablet that boosts the level of hormones to stimulate the release of insulin after a meal by blocking dipeptidyl peptidase-4. Double blind tests were done and without a doubt proved that effectiveness of the drug without side effects and proved to be an upbeat moment of medical news in 2011.
2) Discoveries in the Fight Against Melanoma – After numerous tests and scrutiny from the eye of many a regulatory affairs manager, the drug aimed at patients with advanced stages of melanoma called Ipilimumab is said to elongate the life of up to 23% of patients to a longer life of 2 years or more. With increasing rates internationally, this medical news is welcome.
3) Vaccine for Prostate Cancer – After over 15 years of research, a vaccine has been approved by the FDA and has been said to increase the lives of patients by up to 4 months with correct use. While Sipuleucel-T does not cure metastatic prostate cancer, it does hold great hope for the future and further drugs could cure the long term fatal disease.
These are some of the best medical news stories of 2011, and without a doubt as medical technology moves forward, we’ll be seeing more amazing stories and breakthroughs in 2012 to ensure humans live longer and in less pain.
October 20, 2011
Eucomed, the European Medical Technology Industry Association, has launched a new 5 year strategy plan to reform healthcare in the European Union. Through constant innovation, the industry body has declared the goals of providing cost effective healthcare, through various reforms to ensure that all professions from surgeons to clinical assistant jobs are made sustainable and cost effective to the patient for years to come. The Economist Intelligence Unit, released its report “Future Proofing Western Europe’s Healthcare”, which Eucomed endorses, at Med Tech this last week.
The report on medical technology stipulates the urgent need for healthcare systems to be efficient, effective and informed in order to stay at the top of its game of being able to support the growing needs of an aging and growing population. The industry association has pledged its support to helping the productivity of medical technology and assuring that these developments are well supported. The focus needs to be on medical technology focused on sustainable growth that can consistently perform under increasing costs and reduced budgets, a trend see in the industry lately. Through support from Eucomed, it will be focus on industry leaders and clinical manager jobs to ensure that value based innovation are the outcome from the years of research. All of this is going to rely on collaboration between all medical technology stakeholders in the industry.
Eucomed has noted the concerns of the European healthcare industry and has stated that technology, although having one of the smallest expenditures, has the best chance of creating sustainable changes in the industry. For the full story on the reforming strategy proposal by the European Medical Technology Association, click here to view their new website.
July 29, 2011
The first person who will live to see their 150th birthday has already been born. And the first person to live for 1,000 years could be less than 20 years younger. This is merely a prediction but anti aging technology is heading toward that very briskly. Anti aging research is in an attempt to cure the disease which is aging. Banishing diseases which go together with aging will mean that extending life indefinitely is no longer a concept for the imagination but rather a reality in about twenty five years.
Anti aging products and creams are improving but these products don’t cure but rather just post pone what will ultimately happen. Also, you can live a healthy life and you would still lead to your inevitable death. Anti Aging and longevity research will ensure that the same sort of medical control that we have over most infectious diseases today will be possible in the very near future. Soon we will see a time when people will go to their doctors for regular “maintenance,” which by then will include gene therapies, stem cell therapies, immune stimulation and a range of other advanced medical techniques to keep them in good shape and anti aging. With the help of a clinical research associate it wouldn’t matter how long ago you were born because the thing about maintenance is it works indefinitely.
The reason we age is because of cells not deteriorate. Molecular garbage accumulates inside the cell, and eventually it gets in the way of the cell’s workings. Medical professionals and a regulatory affairs manager are working to identify enzymes in other species that can break down the garbage and clean out the cells and the aim then is to devise genetic therapies to give this capability of anti aging to humans. Dead and dying cells will be replaced and the biggest cause of death won’t be old age but rather other accidents. Anti aging will soon be a reality.
July 29, 2011
Birth control has been predominately women’s responsibility over the past years but that is soon to change. If researchers at Columbia University Medical Centre are right men may soon be next in line to utter that infamous line “Oops I forgot to take my pill”. The first male birth control pill that has no negative side effects is under development. This new research was represented at The 93rd Annual Meeting & Expo of the Endocrine Society in Boston, Massachusetts.
Clinical research has proven years ago that Vitamin A reduces or completely stops the production of semen in male specimens. This was once again proven on mice and it was also proven that once normal amounts of vitamin A are restored that fertility returns almost immediately without side effect. This means that the effects on sperm production are merely temporary – the hallmark of birth control.
Some concerns where the effect of Vitamin A to eye sight. Although vitamin A is also crucial for vision, the drug’s developers say it will not affect sight. Another concern was that of sex drive. Unlike other hormone based birth control types, the vitamin A pill is a natural birth control method and will have no negative effects on the users. The male birth control will be an oral contraceptive unlike the steroid male birth control which is an injection based method. The founders of the ‘mice pill’, Drs. Wolgemuth and Chung and regulatory affairs job are enthusiastic about the possibilities, and are now planning longer-term studies to determine how long fertility can be disrupted and still recover after administration of the birth control stops.
July 29, 2011
Every year, the effects of multiple sclerosis claim many innocent lives and there is seemingly no end to this disease. Scientists work tirelessly to perfect a cure, or even a treatment for multiple sclerosis and for some, there is a glimmer of hope. The University of Bristol was given a sizeable donation of one million dollars by the Kenneth and Claudia Silverman Fund and this money will be directly paid into the Phase Two trail stages of a clinical bone marrow therapy, being performed directly on the affected patients.
Various forms of clinical research studies will combine to produce exceptional results. Bone marrow stem cells have displayed excellent progress in regards to curative properties and the marrow itself is known to contain stem cells which are capable of repairing damage in the tissue and other vital organs – this makes the treatment of great interest to those who wish to discover new ways of treating multiple sclerosis and other diseases which affect the nervous system.
The Phase One section of the trial is complete – sorting out the feasible patients from the non-feasible patients; Phase Two is regarding the actual testing of the therapies. One of the professors who has the position of the Pharmacovigilance job said that multiple sclerosis is one of the most common neurological diseases which affects young adults and being able to sort out this issue sooner than later would be of a great benefit to the medical community. The patients were injected with a general anesthesia and then the marrow cells were harvested for filtering and preparation and they were then re-injected back into the marrow. Increased Neuroprotection and immune modulation of multiple sclerosis is the ideal result and with this much money being pumped into it, there can only be a positive result as the outcome.
